Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Return on Assets [ROA] (2010 - 2026)

Updated

Regeneron Pharmaceuticals (REGN) posted Return on Assets [ROA] of 10.48% for Q2 2026, down 1.29 percentage points from 11.77% a year earlier and down 0.38 percentage points from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Return on Assets [ROA] (2010 - 2026) Analysis & Trends

For FY2025, Regeneron Pharmaceuticals' Return on Assets [ROA] came in at 11.50%, down 0.95 percentage points from FY2024.

  • Annual Return on Assets [ROA] has declined for four consecutive years, with a five-year change of -10.48 percentage points (FY2020 to FY2025).
  • In prior years, Regeneron Pharmaceuticals' Return on Assets [ROA] was 12.46% in FY2024 (-0.24 pp), 12.69% in FY2023 (-3.18 pp), 15.88% in FY2022 (-22.04 pp) and 37.91% in FY2021 (+15.93 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Assets [ROA] since Q2 2015.
  • On a year-over-year basis, Return on Assets [ROA] has declined in each of the last five quarters, with an average year-over-year change of -0.54 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q4 2021, with a gain of 11.76 percentage points; the weakest was Q4 2022, with a drop of 17.64 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was 10.86% (Q1 2026), 11.16% (Q4 2025) and 11.68% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 10.47%
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 4.65%
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 2.45%
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 10.60%
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 9.10%
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 9.29%
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -6.13%
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 2.14%
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn 10.48%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.48%
Mar 31, 2026 10.86%
Dec 31, 2025 11.16%
Sep 30, 2025 11.68%
Jun 30, 2025 11.77%
Mar 31, 2025 11.95%
Dec 31, 2024 11.74%
Sep 30, 2024 12.66%
Jun 30, 2024 12.27%
Mar 31, 2024 11.44%
Dec 31, 2023 12.12%
Sep 30, 2023 12.71%
Jun 30, 2023 14.16%
Mar 31, 2023 14.11%
Dec 31, 2022 15.25%
Sep 30, 2022 19.57%
Jun 30, 2022 21.24%
Mar 31, 2022 30.64%
Dec 31, 2021 32.89%
Sep 30, 2021 30.98%
API Access

Regeneron Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=REGN&period=max&api_key=YOUR_API_KEY